P

Precision AQ

Data-driven drug access and launches

Supervisor - Global Sample Solutions

Full-Time
No salary listed
Expert
Bachelor's
Pune, Maharashtra, India
In PersonMust be able to overlap with U.S. business hours as business needs require.
Biology & BiotechClinical Research Operations

About the job

Requirements
  • A bachelor's degree in life sciences, clinical research, healthcare administration, business, or a related field is preferred; an equivalent combination of education and relevant experience may be considered.
  • Six or more years of relevant experience in sample management, clinical trial operations, laboratory operations, data management, project coordination, or a related environment is preferred.
  • Two or more years of experience leading people, projects, workflows, or operational initiatives is preferred.
  • Experience with customer- or site-facing communications, discrepancy management, issue resolution, and cross-functional coordination.
  • Experience with biospecimen inventory systems, clinical databases, reconciliation activities, or operational reporting tools is preferred.
  • Strong leadership, coaching, workload management, and team development skills.
  • Excellent written and verbal communication skills, including the ability to manage sensitive or escalated customer interactions professionally.
  • Strong analytical, investigative, and problem-solving capabilities with consistent attention to detail.
  • Ability to manage multiple priorities, changing deadlines, and global stakeholders in a fast-paced environment.
  • Ability to interpret operational data, identify trends, and translate findings into clear actions.
  • Proficiency with Microsoft Excel, Microsoft Office applications, reporting tools, and operational dashboards.
  • Strong knowledge of data integrity, documentation, and quality principles.
  • Ability to work effectively across global teams and time zones.
  • Candidates must be legally authorized to work in the country of employment without employer sponsorship.
Responsibilities
  • Oversee and coordinate the day-to-day activities of the Global Sample Solutions Site Outreach team, ensuring timely resolution of sample discrepancies, effective site outreach, accurate data investigations, and discrepancy resolution.
  • Provide operational guidance, training, workload prioritization, and escalation support to Global Sample Solutions Specialists; monitor key performance indicators, turnaround time, quality, and backlog aging while partnering with cross-functional stakeholders on continuous improvement.
  • Lead, mentor, and support Global Sample Solutions Specialists responsible for site outreach, discrepancy resolution, and study support activities.
  • Provide direct supervisory oversight for assigned team members.
  • Coordinate daily workload assignments and priorities to ensure timely follow-up and closure of open discrepancies.
  • Monitor team productivity, quality, key performance indicators, service-level expectations, and backlog aging; communicate risks and recovery plans to leadership.
  • Serve as the primary escalation point for complex discrepancy investigations, customer communication challenges, and cross-functional operational issues.
  • Provide onboarding, role-specific training, coaching, and ongoing development for team members.
  • Conduct routine workload and quality reviews and identify opportunities to improve consistency, efficiency, and compliance.
  • Partner with leadership to support resource planning, workload forecasting, and operational readiness.
  • Support global time zones, including overlap with U.S. business hours as business needs require.
  • Maintain global oversight of unresolved discrepancies identified by internal sample management teams for incoming and outgoing shipments.
  • Ensure adherence to project-specific communication plans, established outreach timelines, documentation standards, and escalation procedures.
  • Liaise with sites, sponsors, contract research organizations, clients, and internal teams to obtain missing information and facilitate timely discrepancy resolution.
  • Review complex or high-impact discrepancies and guide the team on appropriate resolution actions.
  • Ensure resolution actions are clearly documented and communicated to meet customer and business deliverables for turnaround time.
  • Monitor first, second, and final outreach activities, including shipment tracking information and response status, to ensure appropriate follow-up.
  • Monitor discrepancy aging and trends and implement recovery or corrective action plans when performance is at risk.
  • Provide oversight for study close-out activities, including data review, outstanding query resolution, reconciliation support, and sample disposition follow-up.
  • Independently prioritize daily workload, resolve routine operational issues, and escalate high-impact risks to leadership.
  • Provide oversight for unresolved sample data requests, reconciliation queries, and database-related discrepancies.
  • Coordinate with internal stakeholders to investigate, document, and implement approved corrections for data modifications or errors.
  • Support reconciliation between source documentation, sample inventory systems, clinical databases, electronic data capture systems, and client-provided data, as applicable.
  • Ensure sufficient documentation and audit trails are maintained for data corrections and resolution activities.
  • Escalate system or process issues that may affect data integrity, operational timelines, or customer deliverables.
  • Ensure team activities comply with company standard operating procedures, study-specific requirements, documented procedures, and applicable quality standards.
  • Oversee or perform quality control reviews of outreach documentation, discrepancy resolution records, and data updates.
  • Review quality findings and coordinate corrective actions, retraining, or process updates as needed.
  • Maintain audit-ready documentation and support internal audits, client audits, and regulatory inspections, as required.
  • Promote accountability, collaboration, and continuous improvement.
Desired Qualifications
  • A bachelor's degree in life sciences, clinical research, healthcare administration, business, or a related field.
  • Six or more years of relevant experience in sample management, clinical trial operations, laboratory operations, data management, project coordination, or a related environment.
  • Two or more years of experience leading people, projects, workflows, or operational initiatives.
  • Experience with biospecimen inventory systems, clinical databases, reconciliation activities, or operational reporting tools.

About the company

Precision AQ helps pharmaceutical companies get FDA-approved medicines to patients by using data, evidence, and market insights to shape access and launches. Its services combine medical science, commercial strategy, and technology development to create new pathways for drug availability and timely delivery. The company partners with drug makers to plan launches and expansion, using analytical and creative approaches to make medicines reachable and effective in real-world settings. Unlike firms that focus only on science or marketing, Precision AQ blends data-driven insights with strategic execution across development and commercialization to accelerate patient access. The goal is to raise standards in healthcare accessibility and impact by getting the right medicines to the right patients faster.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

New York City, New York

Founded

N/A

Get referred to Precision AQ

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • February 17, 2026 hires Yahya Anvar and Emma Hawe deepen AI and HTA capabilities.
  • August 12, 2026 Candice Subero hire boosts marketing-led customer engagement and commercial growth.
  • Precision AQ’s 2025 Phluence investment advances agentic patient solutions, reducing post-Rx service costs.

What critics are saying

  • Precision AQ reported $314.5 million revenue in 2024, down 7%, signaling slower growth.
  • Phluence integration in November 2025 risks distracting teams while AI patient-service economics remain unproven.
  • If pharma shifts to in-house AI access tools, Precision AQ’s HUB model weakens.

What makes Precision AQ unique

  • Precision AQ works with all top 30 pharma companies and 350+ active engagements in 2026.
  • Its 2024 rebrand unified pricing, HEOR, medical affairs, and omnichannel capabilities under one platform.
  • Precision AQ has launched over 450 drugs, creating embedded launch expertise across therapeutics.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Life Insurance
  • Disability Insurance
  • Paid Vacation
  • Paid Sick Leave
  • Parental Leave
  • Performance Bonus

Company News

PR Newswire
Feb 17th, 2026
Precision AQ expands leadership with AI and data strategy hires to strengthen global biopharma solutions

Precision AQ, a global life sciences commercialisation partner, has appointed two senior leaders to expand its AI and data capabilities. Emma Hawe joins as Senior Vice President, Managing Director for Evidence Synthesis & Decision Modelling, bringing over 25 years of experience in evidence generation and applied statistics. She currently chairs ISPOR's HEOR Excellence—Methodology Award. Yahya Shaikh becomes Senior Vice President, Data Strategy & AI, focusing on strengthening the company's data foundation and advancing AI-enabled solutions. He brings decades of experience in AI, analytics and enterprise data strategy across life sciences and healthcare. The appointments aim to bolster Precision AQ's presence in the EU whilst expanding its global reach. The company works with all 30 top pharmaceutical firms and has launched over 450 drugs across therapeutic areas.

StreetInsider
Nov 18th, 2025
Precision AQ Invests in Phluence Platform

Precision AQ has made a strategic investment in Phluence, enhancing its post-prescription capabilities. This investment allows pharmaceutical manufacturers to virtualize patient services, reduce costs, and improve access through Phluence's advanced agentic workflow management platform. The collaboration aims to modernize patient engagement with AI-driven solutions, offering an alternative to traditional HUB models. This move supports Precision AQ's goal to streamline patient services and accelerate access to therapies.

PR Newswire
Apr 25th, 2025
Precision Aq Expands Industry-Leading Access Experience Team (Aet) With Three Oncology Experts

-- Shraddha Kansagra, PharmD, BCOP, former Clinical Pharmacy Specialist at UT Southwestern, appointed Vice President, Clinical Oncology Solutions ---- Angelica Norrell, PharmD, BCOP, CSP, former Senior Director of Product at Optum, joins as Senior Director, AET ---- Courtney Patterson, PharmD, MBA, former System Director of Oncology Pharmacy Services at Advocate Health, joins as Vice President, Clinical Oncology Solutions --NEW YORK, April 25, 2025 /PRNewswire/ -- Precision AQ, a leader in life sciences commercialization and a driving force in expanding patient access to life-changing therapies, today announced the additions of Shraddha Kansagra, PharmD, BCOP, Angelica Norrell, PharmD, BCOP, CSP, and Courtney Patterson, PharmD, MBA to its Access Experience Team (AET). These experts join Precision AQ's AET, an industry-leading team of former access decision-makers and influencers, to provide critical insights to life science companies and support them in anticipating payer challenges and designing strategies to optimize patient access in oncology.As access decisions in oncology increasingly incorporate both payer and provider perspectives, the additions of Drs. Kansagra, Norrell, and Patterson reflect Precision AQ's commitment to evolving with the landscape. Precision AQ's AET boasts numerous oncology experts, including five Board Certified Oncology Pharmacists (BCOPs), from prominent payer and provider-based institutions across the United States. These new additions further bolster the AET's expertise and capabilities, including driving medical and pharmacy benefit management for Value Based Care, drug coverage policy and formulary design; optimizing patient care through quality improvement initiatives; and overseeing pharmacy and healthcare operations."We are delighted to welcome Shraddha, Angie, and Courtney to Precision AQ, bolstering our AET with additional expertise in oncology, one of the most innovative areas in healthcare," said Chad Clark, President and Chief Operating Officer of Precision Medicine Group. "Together with our existing roster of top-tier access decision makers, as well as our external network of over 100 oncology advisors from leading U.S

PR Newswire
Mar 31st, 2025
Precision Aq Earns Hitrust Implemented, 1-Year I1 Certification For Data Protection And Cybersecurity Risk Management

HITRUST i1 certification confirms Precision AQ's commitment to protecting sensitive data with leading security practices.NEW YORK, March 31, 2025 /PRNewswire/ -- Precision AQ, a leader in guiding life science organizations through the complexities of product commercialization and empowering access to life-changing medicines for all, announced today that its PatientLens platform has achieved HITRUST certification for system and information security.PatientLens transforms healthcare insights and patient program design by reducing friction in patient services and by delivering timely, actionable information to support decision-making. The platform offers a detailed view of insurance coverage, out-of-pocket costs, and medical or medication history. By leveraging tokenized patient data and advanced analytics, PatientLens helps healthcare organizations optimize patient outreach, prioritize cases, and ensure compliance, driving improved outcomes and operational efficiency.The HITRUST Implemented, 1-Year i1 validated assessment and certification process confirms that the PatientLens platform applies a robust set of HITRUST-curated controls. These controls ensure the organization follows leading security practices and maintains a comprehensive cybersecurity program to defend against cyber threats. HITRUST continuously analyzes cyber threat intelligence to keep its control requirements relevant, helping organizations mitigate emerging risks like phishing, brute force attacks, and ransomware, and supporting organizational resilience."The HITRUST i1 validated assessment is a powerful tool for cyber-aware organizations, such as Precision AQ," said Robert Booker, Chief Strategy Officer at HITRUST. "This certification assures the measurement, implementation, and performance of robust information security controls

GlobeNewswire
Mar 4th, 2025
Tenaya Therapeutics Announces Pricing of Public Offering

SOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a...